Proposal to list medical thermometers and single use instruments supplied by Jackson Allison Medical & Surgical Limited

Hospital devices

Consultation Closed

What we’re proposing

PHARMAC is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule from 1 August 2018, through a provisional agreement with Jackson Allison Medical & Surgical Limited (“Jackson Allison”):

  • medical thermometers; and
  • single use instruments.

Consultation closes at 4pm on Thursday, 7 June 2018 and feedback can be emailed to alyssa.currie@pharmac.govt.nz.

What would the effect be?

From 1 August 2018, Jackson Allison’s range of medical thermometers and single use instruments would be listed under the proposed national agreement for all DHBs to purchase under, subject to consultation and approval by PHARMAC’s Board or delegate (“Agreement”).

This Agreement would not be for sole supply, with DHBs continuing to be able to purchase other suppliers’ brands of medical thermometers and single use instruments.

This Agreement would supersede any existing DHB contracts with Jackson Allison for the devices included in the Agreement. Any device listed in the Agreement and purchased by a DHB would be at the price, terms and conditions stated in the Agreement, effective from the date of listing in the Pharmaceutical Schedule.

PHARMAC estimates the national financial impact of this Agreement, across all DHBs, to be a cost increase of $4,400 based on current usage levels.

As part of the Agreement Jackson Allison would provide educational services that would be tailored to the individual needs of DHBs, in formats and at times as required by DHBs.

Pricing for the devices in the Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by PHARMAC.

Who we think will be interested

  • Suppliers and Wholesalers
  • DHB staff:
    • Clinicians
    • Clinical Engineers
    • Procurement and supply chain personnel

About the proposed medical devices

Medical thermometers

Medical thermometers are used to measure a patient’s body temperature. The ability to detect or monitor fever or hypothermia is vital in patient assessment, to guide treatment options and management. The accurate measurement of temperature is important and medical thermometer products come in a range of presentations for different clinical requirements.

Single use instruments

Single use instruments are designed to be used once and then disposed of or destroyed – these are also known as disposable instruments. Some single use instruments may be used in many hospital settings such as operating theatres, emergency departments, wards and clinics.

Why we’re proposing this 

In 2016 PHARMAC issued Requests for Proposals (“RFPs”) for non-exclusive national agreements for listing in the Pharmaceutical Schedule.

PHARMAC has been working with suppliers who responded to the RFPs to seek provisional agreements and this proposal is the latest to arise from these processes. We expect to consult on further proposed agreements with suppliers over the next few months.

Details about our proposal

PHARMAC has entered into a provisional Agreement with Jackson Allison for a range of medical thermometers and single use instruments.

Pricing has been made available to appropriate DHB personnel.

This proposal would result in Schedule listings for 13 medical thermometers and 24 single use instruments. Brand ranges in the Agreement include:

Medical thermometers

  • Boss Systems
  • Clinitrend
  • DeRoyal
  • Koo
  • Nanjing

Single use instruments

  • DeRoyal
  • Evexar
  • KAI Medical
  • Sapimed

To provide feedback

Send us an email: alyssa.currie@pharmac.govt.nz by Thursday 7 June 2018.

All feedback received before the closing date will be considered by PHARMAC’s Board (or its delegate) prior to making a decision on this proposal.

Feedback we receive is subject to the Official Information Act 1982 (OIA) and we will consider any request to have information withheld in accordance with our obligations under the OIA. Anyone providing feedback, whether on their own account or on behalf of an organisation, and whether in a personal or professional capacity, should be aware that the content of their feedback and their identity may need to be disclosed in response to an OIA request.

We are not able to treat any part of your feedback as confidential unless you specifically request that we do, and then only to the extent permissible under the OIA and other relevant laws and requirements. If you would like us to withhold any commercially sensitive, confidential proprietary, or personal information included in your submission, please clearly state this in your submission and identify the relevant sections of your submission that you would like it withheld. PHARMAC will give due consideration to any such request.